161 related articles for article (PubMed ID: 38543186)
21. Solubilisation behaviour of poorly water-soluble drugs during digestion of solid SMEDDS.
Vithani K; Hawley A; Jannin V; Pouton C; Boyd BJ
Eur J Pharm Biopharm; 2018 Sep; 130():236-246. PubMed ID: 29981444
[TBL] [Abstract][Full Text] [Related]
22. 50years of oral lipid-based formulations: Provenance, progress and future perspectives.
Feeney OM; Crum MF; McEvoy CL; Trevaskis NL; Williams HD; Pouton CW; Charman WN; Bergström CAS; Porter CJH
Adv Drug Deliv Rev; 2016 Jun; 101():167-194. PubMed ID: 27089810
[TBL] [Abstract][Full Text] [Related]
23. Development and Characterization of a Self-Nanoemulsifying Drug Delivery System Comprised of Rice Bran Oil for Poorly Soluble Drugs.
Eleftheriadis GK; Mantelou P; Karavasili C; Chatzopoulou P; Katsantonis D; Irakli M; Mygdalia A; Vizirianakis IS; Fatouros DG
AAPS PharmSciTech; 2019 Jan; 20(2):78. PubMed ID: 30635752
[TBL] [Abstract][Full Text] [Related]
24. Optimization of self nanoemulsifying drug delivery system for poorly water-soluble drug using response surface methodology.
Ren S; Mu H; Alchaer F; Chtatou A; Müllertz A
Drug Dev Ind Pharm; 2013 May; 39(5):799-806. PubMed ID: 22871082
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of Hydrogenated Soybean Phosphatidylcholine Matrices Prepared by Hot Melt Extrusion for Oral Controlled Delivery of Water-Soluble Drugs.
Kolbina M; Schulte A; van Hoogevest P; Körber M; Bodmeier R
AAPS PharmSciTech; 2019 Apr; 20(4):159. PubMed ID: 30968304
[TBL] [Abstract][Full Text] [Related]
26. The Development and Optimization of Lipid-Based Self-Nanoemulsifying Drug Delivery Systems for the Intravenous Delivery of Propofol.
Kazi M; Alqahtani A; Alharbi M; Ahmad A; Hussain MD; Alothaid H; Aldughaim MS
Molecules; 2023 Feb; 28(3):. PubMed ID: 36771156
[TBL] [Abstract][Full Text] [Related]
27. Studying the effect of lipid chain length on the precipitation of a poorly water soluble drug from self-emulsifying drug delivery system on dispersion into aqueous medium.
Prasad D; Chauhan H; Atef E
J Pharm Pharmacol; 2013 Aug; 65(8):1134-44. PubMed ID: 23837581
[TBL] [Abstract][Full Text] [Related]
28. Supersaturated silica-lipid hybrids (super-SLH): An improved solid-state lipid-based oral drug delivery system with enhanced drug loading.
Schultz HB; Thomas N; Rao S; Prestidge CA
Eur J Pharm Biopharm; 2018 Apr; 125():13-20. PubMed ID: 29277724
[TBL] [Abstract][Full Text] [Related]
29. Development of self-microemulsifying drug delivery system for oral delivery of poorly water-soluble nutraceuticals.
Shah AV; Desai HH; Thool P; Dalrymple D; Serajuddin ATM
Drug Dev Ind Pharm; 2018 Jun; 44(6):895-901. PubMed ID: 29254385
[TBL] [Abstract][Full Text] [Related]
30. Maximizing the Oral Bioavailability of Poorly Water-Soluble Drugs Using Novel Oil-Like Materials in Lipid-Based Formulations.
Abbasi S; Higashino H; Sato Y; Minami K; Kataoka M; Yamashita S; Harashima H
Mol Pharm; 2021 Sep; 18(9):3281-3289. PubMed ID: 34351769
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the in vitro cytotoxicity among phospholipid-based parenteral drug delivery systems: Emulsions, liposomes and aqueous lecithin dispersions (WLDs).
Płaczek M; Wątróbska-Świetlikowska D; Stefanowicz-Hajduk J; Drechsler M; Ochocka JR; Sznitowska M
Eur J Pharm Sci; 2019 Jan; 127():92-101. PubMed ID: 30342174
[TBL] [Abstract][Full Text] [Related]
32. Assessment of cell viability and permeation enhancement in presence of lipid-based self-emulsifying drug delivery systems using Caco-2 cell model: Polysorbate 80 as the surfactant.
Bu P; Ji Y; Narayanan S; Dalrymple D; Cheng X; Serajuddin AT
Eur J Pharm Sci; 2017 Mar; 99():350-360. PubMed ID: 28024890
[TBL] [Abstract][Full Text] [Related]
33. Ionic Liquid Forms of the Antimalarial Lumefantrine in Combination with LFCS Type IIIB Lipid-Based Formulations Preferentially Increase Lipid Solubility, In Vitro Solubilization Behavior and In Vivo Exposure.
Tay E; Nguyen TH; Ford L; Williams HD; Benameur H; Scammells PJ; Porter CJH
Pharmaceutics; 2019 Dec; 12(1):. PubMed ID: 31877828
[TBL] [Abstract][Full Text] [Related]
34. Development and pharmacokinetic evaluation of a self-nanoemulsifying drug delivery system for the oral delivery of cannabidiol.
Kok LY; Bannigan P; Sanaee F; Evans JC; Dunne M; Regenold M; Ahmed L; Dubins D; Allen C
Eur J Pharm Sci; 2022 Jan; 168():106058. PubMed ID: 34763088
[TBL] [Abstract][Full Text] [Related]
35. The conflict between in vitro release studies in human biorelevant media and the in vivo exposure in rats of the lipophilic compound fenofibrate.
Do TT; Van Speybroeck M; Mols R; Annaert P; Martens J; Van Humbeeck J; Vermant J; Augustijns P; Van den Mooter G
Int J Pharm; 2011 Jul; 414(1-2):118-24. PubMed ID: 21596119
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of critical formulation parameters in design and differentiation of self-microemulsifying drug delivery systems (SMEDDSs) for oral delivery of aciclovir.
Janković J; Djekic L; Dobričić V; Primorac M
Int J Pharm; 2016 Jan; 497(1-2):301-11. PubMed ID: 26611669
[TBL] [Abstract][Full Text] [Related]
37. High drug loading self-microemulsifying/micelle formulation: design by high-throughput formulation screening system and in vivo evaluation.
Sakai K; Obata K; Yoshikawa M; Takano R; Shibata M; Maeda H; Mizutani A; Terada K
Drug Dev Ind Pharm; 2012 Oct; 38(10):1254-61. PubMed ID: 22339057
[TBL] [Abstract][Full Text] [Related]
38. Colloidal aspects of dispersion and digestion of self-dispersing lipid-based formulations for poorly water-soluble drugs.
Vithani K; Jannin V; Pouton CW; Boyd BJ
Adv Drug Deliv Rev; 2019 Mar; 142():16-34. PubMed ID: 30677448
[TBL] [Abstract][Full Text] [Related]
39. Small-volume
Khan NF; Salim M; Binte Abu Bakar SY; Ristroph K; Prud'homme RK; Hawley A; Boyd BJ; Clulow AJ
Int J Pharm X; 2022 Dec; 4():100113. PubMed ID: 35243327
[TBL] [Abstract][Full Text] [Related]
40. Preparation of Solid Self-Nanoemulsifying Drug Delivery Systems (S-SNEDDS) by Co-Extrusion of Liquid SNEDDS and Polymeric Carriers-A New and Promising Formulation Approach to Improve the Solubility of Poorly Water-Soluble Drugs.
Schmied FP; Bernhardt A; Klein S
Pharmaceuticals (Basel); 2022 Sep; 15(9):. PubMed ID: 36145356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
